Home/Filings/4/0001453687-25-000022
4//SEC Filing

Kalayoglu Murat 4

Accession 0001453687-25-000022

CIK 0001453687other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:20 PM ET

Size

7.8 KB

Accession

0001453687-25-000022

Insider Transaction Report

Form 4
Period: 2025-01-02
Kalayoglu Murat
Director10% Owner
Transactions
  • Award

    Common Stock

    2025-01-02+2,600508,977 total
  • Award

    Stock Option (Right to Buy)

    2025-01-02+7,8007,800 total
    Exercise: $16.93From: 2026-01-02Exp: 2035-01-01Common Stock (7,800 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    4,555,260
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.
  • [F2]Shares are held in a trust (the "Trust") for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust.

Issuer

Cartesian Therapeutics, Inc.

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0002000002

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:20 PM ET
Size
7.8 KB